C

Celsion Corp
F:CBOC

Watchlist Manager
Celsion Corp
F:CBOC
Watchlist
Price: 0.286 EUR -10.63%
Market Cap: 96.8k EUR

Operating Margin
Celsion Corp

0%
Current
-3 500%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.5m
/
Revenue
0

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Celsion Corp
LSE:0HUZ
198.5m USD N/A
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
404.4B USD
33%
US
Amgen Inc
NASDAQ:AMGN
178.3B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
155.5B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD
28%
AU
CSL Ltd
ASX:CSL
83B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD
8%
NL
argenx SE
XBRU:ARGX
44.1B EUR
22%
No Stocks Found

Celsion Corp
Glance View

Market Cap
96.8k EUR
Industry
Biotechnology

Celsion Corp .is a clinical stage oncology drug company. The company is headquartered in Lawrence Township, New Jersey and currently employs 29 full-time employees. The firm is focused on advancing a portfolio of treatments, including deoxyribonucleic acid (DNA)-based immunotherapies, vaccines and directed chemotherapies through clinical trials and eventual commercialization. The firm's product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, its heat-activated liposomal encapsulation of doxorubicin, under investigator-sponsored development for several cancer indications. The company has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies and vaccines, and other anti-cancer DNA or ribonucleic acid (RNA) therapies. Both are synthetic, non-viral vectors with capability in nucleic acid cellular transfection. Its TheraPlas is a technology platform for the delivery of DNA and messenger RNA (mRNA) therapeutics via synthetic non-viral carriers.

CBOC Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.5m
/
Revenue
0
What is the Operating Margin of Celsion Corp?

Based on Celsion Corp's most recent financial statements, the company has Operating Margin of 0%.

Back to Top